Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 7 February 2006. doi:10.1136/thx.2005.053470
Thorax 2006;61:559-567
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Web-only appendices
Right arrow All Versions of this Article:
thx.2005.053470v1
thx.2005.053470v2
61/7/559    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, M M
Right arrow Articles by O’Donnell, D E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, M M
Right arrow Articles by O’Donnell, D E
Topic Collections
Right arrowRelevant Article

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD

M M Peters, K A Webb, D E O’Donnell

Respiratory Investigation Unit, Department of Medicine, Queen’s University, Kingston, Ontario, Canada

Correspondence to:
Correspondence to:
Dr D E O’Donnell
102 Stuart Street, Kingston, Ontario K7L 2V6, Canada; odonnell{at}post.queensu.ca

Background: Studies examining the physiological interactions of oxygen (O2) and bronchodilators (BD) during exercise in chronic obstructive pulmonary disease (COPD) should provide new insights into mechanisms of exercise intolerance. We examined the effects of O2 and BD, alone and in combination, on dyspnoea, ventilation (VE), breathing pattern, operating lung volumes, and exercise endurance.

Methods: In a randomised, double blind, crossover study, 16 patients with COPD (mean (SE) FEV1 43(3)% predicted) performed pulmonary function tests and an incremental exercise test, then completed four visits in which they received either nebulised BD (ipratropium 0.5 mg + salbutamol 2.5 mg) or placebo (PL) with either 50% O2 or room air (RA). After 90–105 minutes the patients performed pulmonary function tests, then breathed RA or O2 during symptom limited constant load exercise at 75% peak work rate.

Results: With BD the mean (SE) increase in inspiratory capacity (IC) was 0.3 (0.1) l (p<0.05) at rest and during exercise, permitting greater tidal volume (VT) expansion during exercise and a greater peak VE. With O2, VE decreased during exercise as a result of decreased breathing frequency (F), with no significant change in IC. During exercise with BD+O2, IC and VT increased, F decreased, and VE did not change. Dyspnoea decreased with all interventions at a standardised time during exercise compared with PL+RA (p<0.05). Endurance time was significantly (p<0.05) greater with BD+O2 (10.4 (1.6) min) than with O2 (8.5 (1.4) min), BD (7.1 (1.3) min) and PL+RA (5.4 (0.9) min).

Conclusion: By combining the benefits of BD (reduced hyperinflation) and O2 (reduced ventilatory drive), additive effects on exercise endurance were observed in patients with normoxic COPD.


Abbreviations: BD, bronchodilator; COPD, chronic obstructive pulmonary disease; EELV, end expiratory lung volume; EILV, end inspiratory lung volume; F, breathing frequency; FEV1, forced expired volume in 1 second; FRC, functional residual capacity; FVC, forced vital capacity; IC, inspiratory capacity; IRV, inspiratory reserve volume; O2, oxygen; PaCO2, arterial carbon dioxide tension; PImax, maximal inspiratory pressure; PEFR, peak expiratory flow rate; PL, placebo; RA, room air; RV, residual volume; SaO2, oxygen saturation; TI, TE, inspiratory and expiratory time; TLC, total lung capacity; TLCO, lung carbon monoxide transfer factor; VCO2, carbon dioxide output; VE, minute ventilation; VO2, oxygen consumption; VT, total volume

Keywords: chronic obstructive pulmonary disease; bronchodilators; oxygen; exercise; dyspnoea; lung hyperinflation


Relevant Article

Airwaves
Wisia Wedzicha
Thorax 2006 61: 551. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
ThoraxHome page
A Borghi-Silva, C C Oliveira, C Carrascosa, J Maia, D C Berton, F Queiroga Jr, E M Ferreira, D R Almeida, L E Nery, and J A Neder
Respiratory muscle unloading improves leg muscle oxygenation during exercise in patients with COPD
Thorax, October 1, 2008; 63(10): 910 - 915.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. E. O'Donnell and K. A. Webb
The major limitation to exercise performance in COPD is dynamic hyperinflation
J Appl Physiol, August 1, 2008; 105(2): 753 - 755.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. B. West, P. D. Wagner, J. A. Neder, G. L. Scano, N. L. Jones, S. G. Zakynthinos, I. Vogiatzis, L. Nici, P. M. Calverley, H. R. Gosker, et al.
The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles vs. lower limb muscle dysfunction vs. dynamic hyperinflation
J Appl Physiol, August 1, 2008; 105(2): 758 - 762.
[Full Text] [PDF]


Home page
ThoraxHome page
D Jensen, K Amjadi, V Harris-McAllister, K A Webb, and D E O'Donnell
Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD
Thorax, July 1, 2008; 63(7): 606 - 613.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Albert and P. M. A. Calverley
Drugs (including oxygen) in severe COPD
Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Calverley
Understanding Breathlessness in Mild Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 564 - 565.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. Ofir, P. Laveneziana, K. A. Webb, and D. E. O'Donnell
Ventilatory and perceptual responses to cycle exercise in obese women
J Appl Physiol, June 1, 2007; 102(6): 2217 - 2226.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. D. Marciniuk, S. J. Butcher, J. K. Reid, G. F. MacDonald, N. D. Eves, R. Clemens, and R. L. Jones
The Effects of Helium-Hyperoxia on 6-min Walking Distance in COPD: A Randomized, Controlled Trial
Chest, June 1, 2007; 131(6): 1659 - 1665.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. E. O'Donnell, R. B. Banzett, V. Carrieri-Kohlman, R. Casaburi, P. W. Davenport, S. C. Gandevia, A. F. Gelb, D. A. Mahler, and K. A. Webb
Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease: A Roundtable
Proceedings of the ATS, May 1, 2007; 4(2): 145 - 168.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
E. F. M. Wouters
Nonpharmacological modulation of dynamic hyperinflation
Eur. Respir. Rev., December 1, 2006; 15(100): 90 - 96.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. E. O'Donnell, A. L. Hamilton, and K. A. Webb
Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD
J Appl Physiol, October 1, 2006; 101(4): 1025 - 1035.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R Casaburi
Combination therapy for exercise intolerance in COPD.
Thorax, July 1, 2006; 61(7): 551 - 552.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society